Prestige Consumer Healthcare
PBH
272 hedge funds and large institutions have $3.03B invested in Prestige Consumer Healthcare in 2021 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 93 increasing their positions, 99 reducing their positions, and 17 closing their positions.
159% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 17
10% more funds holding
Funds holding: 248 → 272 (+24)
6% more capital invested
Capital invested by funds: $2.85B → $3.03B (+$178M)
0.51% less ownership
Funds ownership: 101.39% → 100.88% (-0.51%)
6% less repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 99
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$14M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$7.94M |
| 3 |
Renaissance Technologies
New York
|
+$6.7M |
| 4 |
BlackRock
New York
|
+$6.61M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$6.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$68.4M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$13.9M |
| 3 |
TCAM
Turtle Creek Asset Management
Toronto,
Ontario, Canada
|
-$11.8M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$8.02M |
| 5 |
Millennium Management
New York
|
-$6.89M |
PBH Hedge Fund Activity: Q4 2021 in Review
272 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q4 2021, worth a combined $3.03B — up 6.3% from $2.85B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new PBH positions and 17 closed out — a net gain of 27 holders — while 93 added to existing stakes and 99 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $14M. The largest seller was Wells Fargo, cutting an estimated $68.4M.
- 272 institutional investors held Prestige Consumer Healthcare (PBH) as of Q4 2021, up from 248 in Q3 2021.
- Funds reported $3.03B of Prestige Consumer Healthcare stock for Q4 2021, up 6.3% quarter-over-quarter.
- 44 funds opened new Prestige Consumer Healthcare positions in Q4 2021 and 17 closed out, a net change of +27 holders.
- The largest Prestige Consumer Healthcare buyer in Q4 2021 was Goldman Sachs, an estimated $14M added.
- The largest Prestige Consumer Healthcare seller in Q4 2021 was Wells Fargo, an estimated $68.4M sold.
Based on aggregated 13F filings for Q4 2021.